Research Article

Fertility, Pregnancy Rate, and Neonatal Outcome of Patient with Adenomyosis

Ida Bagus Putra Praja Adnyana
Bali Royal Hospital, Denpasar, Indonesia
I Gusti Ngurah Bagus Surya Udayana
Hasan Sadikin Hospital, Indonesia
Made Angga Diningrat
Bali Royal Hospital, Indonesia
William Alexander Setiawan
Sanglah General Hospital, Indonesia
* Corresponding author
DOI icon 10.24018/ejmed.2022.4.5.1386

Read Counter
689

Downloads
427

Citations

Share

Article Sidebar

Submitted 2022-06-12
Published 2022-10-23

Read counter = 689 times

Table of Contents

Article Main Content

This study aimed to look at the link between adenomyosis and fertility, pregnancy, and neonatal outcomes. Until April 2022, an electronic search was conducted utilizing the Medline, Pubmed, and Cochrane databases. There were seventeen observational studies in total. After assisted reproductive technology, adenomyosis was linked to a reduced clinical pregnancy rate (OR 0.69; 95 percent CI 0.51, 0.94) and a greater miscarriage rate (OR 2.17; 95 percent CI 1.25, 3.79) (ART). The lower clinical pregnancy rate was more substantial in the subset of individuals with brief downregulation regimens. Similar relationships were seen after age adjustment. Preeclampsia, premature delivery, cesarean section, fetal malpresentation, small-for-gestational-age infancy, and postpartum hemorrhage were also substantially linked to adenomyosis, which was confirmed after adjusting for age and mode of conception. Finally, adenomyosis is a disease that affects the muscles.

Keywords: Adenomyosis, fertility, pregnancy rate

References

  1. Abbott JA. Adenomyosis and Abnormal Uterine Bleeding (AUB-A)—Pathogenesis, diagnosis, and management. Best Practice & Research Clinical Obstetrics & Gynaecology. 2017; 40: 68-81.
    DOI  |   Google Scholar
  2. Nirgianakis K, Gasparri ML, Radan AP, Villiger A, McKinnon B, Mosimann B, et al. Obstetric complications after laparoscopic excision of posterior deep infiltrating endometriosis: a case-control study. Fertility and Sterility. 2018; 110(3): 459-466.
    DOI  |   Google Scholar
  3. Horton J, Sterrenburg M, Lane S, Maheshwari A, Li TC, Cheong Y. Reproductive, obstetric, and perinatal outcomes of women with adenomyosis and endometriosis: a systematic review and meta-analysis. Human Reproduction Update. 2019; 25(5): 593-633.
    DOI  |   Google Scholar
  4. Vercellini P, Consonni D, Dridi D, Bracco B, Frattaruolo MP, Somigliana E. Uterine adenomyosis and in vitro fertilization outcome: a systematic review and meta-analysis. Human Reproduction. 2014; 29(5): 964-977.
    DOI  |   Google Scholar
  5. Juang CM, Chou P, Yen MS, Twu NF, Horng HC, Hsu WL. Adenomyosis and risk of preterm delivery. BJOG: An International Journal of Obstetrics & Gynaecology. 2007; 114(2): 165-169.
    DOI  |   Google Scholar
  6. Yamaguchi A, Kyozuka H, Fujimori K, Hosoya M, Yasumura S, Yokoyama T, et al. Risk of preterm birth, low birthweight and small-for-gestational-age infants in pregnancies with adenomyosis: A cohort study of the Japan Environment and Children's Study. Acta Obstet Gynecol Scand. 2019; 98(3): 359-364.
    DOI  |   Google Scholar
  7. Mochimaru A, Aoki S, Oba MS, Kurasawa K, Takahashi T, Hirahara F. Adverse pregnancy outcomes associated with adenomyosis with uterine enlargement: Pregnancy in women with adenomyosis. J Obstet Gynaecol Res. 2015; 41(4): 529-533.
    DOI  |   Google Scholar
  8. Hashimoto A, Iriyama T, Sayama S, Nakayama T, Komatsu A, Miyauchi A, et al. Adenomyosis and adverse perinatal outcomes: increased risk of second trimester miscarriage, preeclampsia, and placental malposition. The Journal of Maternal-Fetal & Neonatal Medicine. 2018; 31(3): 364-369.
    DOI  |   Google Scholar
  9. Shin GH, Toto EL, Schey R. Pregnancy and Postpartum Bowel Changes: Constipation and Fecal Incontinence: American Journal of Gastroenterology. 2015; 110(4): 521-529.
    DOI  |   Google Scholar
  10. Sharma S, Bathwal S, Agarwal N, Chattopadhyay R, Saha I, Chakravarty B. Does presence of adenomyosis affect reproductive outcome in IVF cycles? A retrospective analysis of 973 patients. Reproductive BioMedicine Online. 2019; 38(1): 13-21.
    DOI  |   Google Scholar
  11. Scala C, Maggiore ULR, Racca A, Barra F, Vellone VG, Venturini PL, et al. Influence of adenomyosis on pregnancy and perinatal outcomes in women with endometriosis. Ultrasound Obstet Gynecol. 2018; 52(5): 666-671.
    DOI  |   Google Scholar
  12. Thalluri V, Tremellen KP. Ultrasound diagnosed adenomyosis has a negative impact on successful implantation following GnRH antagonist IVF treatment. Human Reproduction. 2012; 27(12): 3487-3492.
    DOI  |   Google Scholar
  13. Imaoka I, Ascher SM, Sugimura K, Takahashi K, Li H, Cuomo F, et al. MR imaging of diffuse adenomyosis changes after GnRH analog therapy. J Magn Reson Imaging. 2002; 15(3): 285-290.
    DOI  |   Google Scholar
  14. Costello MF, Lindsay K, McNally G. The effect of adenomyosis on in vitro fertilisation and intra-cytoplasmic sperm injection treatment outcome. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2011; 158(2): 229-234.
    DOI  |   Google Scholar
  15. Mijatovic V, Florijn E, Halim N, Schats R, Hompes P. Adenomyosis has no adverse effects on IVF/ICSI outcomes in women with endometriosis treated with long-term pituitary down-regulation before IVF/ICSI. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2010; 151(1): 62-65.
    DOI  |   Google Scholar
  16. Park CW, Choi MH, Yang KM, Song IO. Pregnancy rate in women with adenomyosis undergoing fresh or frozen embryo transfer cycles following gonadotropin-releasing hormone agonist treatment. Clin Exp Reprod Med. 2016; 43(3): 169.
    DOI  |   Google Scholar
  17. Niu Z, Chen Q, Sun Y, Feng Y. Long-term pituitary downregulation before frozen embryo transfer could improve pregnancy outcomes in women with adenomyosis. Gynecological Endocrinology. 2013; 29(12): 1026-1030.
    DOI  |   Google Scholar
  18. Surrey ES. To suppress or not to suppress? If that is the question, has it been answered? Fertility and Sterility. 2020; 113(4): 763-764.
    DOI  |   Google Scholar
  19. Wei D, Liu JY, Sun Y, Shi Y, Zhang B, Liu JQ, et al. Frozen versus fresh single blastocyst transfer in ovulatory women: a multicentre, randomised controlled trial. The Lancet. 2019; 393(10178): 1310-1318.
    DOI  |   Google Scholar
  20. Chapron C, Tosti C, Marcellin L, Bourdon M, Lafay-Pillet MC, Millischer AE, et al. Relationship between the magnetic resonance imaging appearance of adenomyosis and endometriosis phenotypes. Human Reproduction. 2017; 32(7): 1393-1401.
    DOI  |   Google Scholar
  21. Younes G, Tulandi T. Effects of adenomyosis on in vitro fertilization treatment outcomes: a meta-analysis. Fertility and Sterility. 2017; 108(3): 483-490.e3.
    DOI  |   Google Scholar
  22. Maubon A, Faury A, Kapella M, Pouquet M, Piver P. Uterine junctional zone at magnetic resonance imaging: A predictor of in vitro fertilization implantation failure: MRI uterine junctional zone and IVF failure. Journal of Obstetrics and Gynaecology Research. 2010; 36(3): 611-618.
    DOI  |   Google Scholar
  23. Gordts S, Grimbizis G, Campo R. Symptoms and classification of uterine adenomyosis, including the place of hysteroscopy in diagnosis. Fertility and Sterility. 2018; 109(3): 380-388.e1.
    DOI  |   Google Scholar
  24. Van den Bosch T, de Bruijn AM, de Leeuw RA, Dueholm M, Exacoustos C, Valentin L, et al. Sonographic classification and reporting system for diagnosing adenomyosis. Ultrasound Obstet Gynecol. 2019; 53(5): 576-582.
    DOI  |   Google Scholar
  25. Bazot M, Daraï E. Role of transvaginal sonography and magnetic resonance imaging in the diagnosis of uterine adenomyosis. Fertility and Sterility. 2018; 109(3): 389-397.
    DOI  |   Google Scholar